Related references
Note: Only part of the references are listed.The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years
Ayse Kubra Karaboga Arslan et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2022)
Biomedical Applications and Bioavailability of Curcumin-An Updated Overview
Soo-In Sohn et al.
PHARMACEUTICS (2021)
Anticancer Mechanism of Curcumin on Human Glioblastoma
Shu Chyi Wong et al.
NUTRIENTS (2021)
The Role of Curcumin in Cancer Treatment
Vasiliki Zoi et al.
BIOMEDICINES (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer
Yasmeen M. Attia et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Reductive metabolites of curcumin and their therapeutic effects
Achyut Pandey et al.
HELIYON (2020)
Curcumin exerts cytotoxicity dependent on reactive oxygen species accumulation in non-small-cell lung cancer cells
Cuijuan Wang et al.
FUTURE ONCOLOGY (2019)
A Review of Curcumin and Its Derivatives as Anticancer Agents
Mhd Anas Tomeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Is curcumin bioavailability a problem in humans: lessons from clinical trials
Ajaikumar B. Kunnumakkara et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Immune checkpoint inhibitors in non-small cell lung cancer: A bird's eye view
Humera Memon et al.
LIFE SCIENCES (2019)
The fallacy of enzymatic hydrolysis for the determination of bioactive curcumin in plasma samples as an indication of bioavailability: a comparative study
Sidney J. Stohs et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Dietary Curcumin: Correlation between Bioavailability and Health Potential
Michele Dei Cas et al.
NUTRIENTS (2019)
Curcumin prevented human autocrine growth hormone (GH) signaling mediated NF-κB activation and miR-183-96-182 cluster stimulated epithelial mesenchymal transition in T47D breast cancer cells
Ajda Coker-Gurkan et al.
MOLECULAR BIOLOGY REPORTS (2019)
Heterogeneity of breast cancer: The importance of interaction between different tumor cell populations
Indre Januskeviciene et al.
LIFE SCIENCES (2019)
Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells
Ajda Coker-Gurkan et al.
AMINO ACIDS (2018)
A novel synthetic curcumin derivative MHMM-41 induces ROS-mediated apoptosis and migration blocking of human lung cancer cells A549
Guang-Zhou Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Curcumin enhances the anti-cancer effects of Paris Saponin II in lung cancer cells
Shuli Man et al.
CELL PROLIFERATION (2018)
Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis
Marcia Cruz-Correa et al.
GASTROENTEROLOGY (2018)
Curcumin suppressed the prostate cancer by inhibiting JNK pathways via epigenetic regulation
Wanli Zhao et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2018)
Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling
Hongbing Fu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Detection of Plasma Curcuminoids from Dietary Intake of Turmeric-Containing Food in Human Volunteers
Jagdish Mahale et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Curcumin increases breast cancer cell sensitivity to cisplatin by decreasing FEN1 expression
Jiao Zou et al.
Oncotarget (2018)
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
S. Lheureux et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition to CRPC status
K. Kavya et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)
Curcumin potentiates the potent antitumor activity of ACN against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways
Jun Zhao et al.
ONCOTARGETS AND THERAPY (2017)
Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines
Puteri Baharuddin et al.
ONCOLOGY REPORTS (2016)
Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring
Elias Jabbour et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The therapeutic potential of mTOR inhibitors in breast cancer
Linda S. Steelman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer
Sherry X. Yang et al.
CANCER TREATMENT REVIEWS (2016)
Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study
Jalal Hejazi et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2016)
Therapeutic Potential of Curcumin for the Treatment of Brain Tumors
Neil V. Klinger et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis
Carlos J. Diaz Osterman et al.
PANCREAS (2016)
Molecular targets of curcumin for cancer therapy: an updated review
Pandima Devi Kasi et al.
TUMOR BIOLOGY (2016)
Activation of PPARγ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence
H. Jin et al.
CELL DEATH & DISEASE (2016)
Anti-cancer effects of curcumin on lung cancer through the inhibition of EZH2 and NOTCH1
Guo-Qing Wu et al.
ONCOTARGET (2016)
Cancer-selective cytotoxic Ca2+ overload in acute myeloid leukemia cells and attenuation of disease progression in mice by synergistically acting polyphenols curcumin and carnosic acid
Stella Pesakhov et al.
ONCOTARGET (2016)
Chronic inflammatory mediators enhance prostate cancer development and progression
Dinesh Thapa et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas
Alfeu Zanotto-Filho et al.
CANCER LETTERS (2015)
Cancer stem cells in glioblastoma
Justin D. Lathia et al.
GENES & DEVELOPMENT (2015)
Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT/mTOR pathway and BCR/ABL gene expression in Ph plus acute lymphoblastic leukemia
Yong Guo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway
Zhiming Zhao et al.
MOLECULAR MEDICINE REPORTS (2015)
Modulatory Effects of Curcumin and Tyrphostins (AG494 and AG1478) on Growth Regulation and Viability of LN229 Human Brain Cancer Cells
Agnieszka Bojko et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2015)
Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway
Hai Jin et al.
ONCOLOGY REPORTS (2015)
Targeting Cdc20 as a novel cancer therapeutic strategy
Lixia Wang et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Progress in the knowledge and treatment of advanced pancreatic cancer: From benchside to bedside
Helmut Oettle
CANCER TREATMENT REVIEWS (2014)
Inhibitory Effect of Turmeric Curcuminoids on FLT3 Expression and Cell Cycle Arrest in the FLT3-Overexpressing EoL-1 Leukemic, Cell Line
Singkome Tima et al.
JOURNAL OF NATURAL PRODUCTS (2014)
The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes
Christina Schiborr et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: the Golden Pigment from Golden Spice
Sahdeo Prasad et al.
CANCER RESEARCH AND TREATMENT (2014)
Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2013)
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (TheracurminA®) in cancer patients
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration-A Clinical Pilot Study Including Assessment of Patient Acceptability
Glen R. B. Irving et al.
CANCER PREVENTION RESEARCH (2013)
Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression
Bin Bao et al.
CANCER RESEARCH (2012)
Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2
Peter H. Killian et al.
CARCINOGENESIS (2012)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Upregulation of p53 Expression in Patients with Colorectal Cancer by Administration of Curcumin
Zhen-Yu He et al.
CANCER INVESTIGATION (2011)
Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal Neoplasia
Robert E. Carroll et al.
CANCER PREVENTION RESEARCH (2011)
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells
Jia Rao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Purusotam Basnet et al.
MOLECULES (2011)
Genomic and Epigenetic Profiles of Gastric Cancer: Potential Diagnostic and Therapeutic Applications
Keishi Yamashita et al.
SURGERY TODAY (2011)
Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia
Veena S Ghalaut et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2011)
Inhibiting NF-kappa B activation by small molecules as a therapeutic strategy
Subash C. Gupta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
Mathilde Bayet-Robert et al.
CANCER BIOLOGY & THERAPY (2010)
Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia
Ana P. Gonzalez-Rodriguez et al.
LEUKEMIA & LYMPHOMA (2010)
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
Ron Epelbaum et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Combined Inhibitory Effects of Soy Isoflavones and Curcumin on the Production of Prostate-Specific Antigen
Hisamitsu Ide et al.
PROSTATE (2010)
Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
Asish K. Ghosh et al.
CLINICAL CANCER RESEARCH (2009)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Bioavailability of curcumin: Problems and promises
Preetha Anand et al.
MOLECULAR PHARMACEUTICS (2007)
Curcumin blocks activation of pancreatic stellate cells
A Masamune et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance
RA Sharma et al.
CLINICAL CANCER RESEARCH (2004)
Therapeutic potential of curcumin in human prostate cancer - I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells
T Dorai et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2000)
Share Paper
